6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Hepatitis D: new trials by email Literature Review of Hepatitis D trials Research Report on Hepatitis D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection Lonafarnib, Ritonavir - Hepatitis D, Chronic | Phase 3 | Completed | Soroka University Medical Center | 10 | 2021-05-15 | 2026-04-30 |
| Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD) Bulevirtide - Chronic Hepatitis Delta | Phase 3 | Completed | Gilead Sciences | 150 | 2019-04-17 | 2025-08-22 |
| Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a Lonafarnib, Ritonavir, PEG IFN-alfa-2a - Hepatitis Delta Virus | Phase 3 | Completed | Eiger BioPharmaceuticals | 407 | 2018-12-01 | 2023-04-14 |
| A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. peginterferon alfa-2a [Pegasys], placebo, tenofovir - Hepatitis D, Chronic | Phase 3 | Completed | Hoffmann-La Roche | 50 | 2010-02-16 | 2019-01-14 |
| Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) Peginterferon alfa-2b (PegIntron, SCH 54031) - Hepatitis D, Chronic, Hepatitis B, Chronic | Phase 3 | Completed | Merck Sharp & Dohme LLC | 68 | 2005-12-01 | 2017-04-06 |
| A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) Pegylated Interferon (PEG-IFN) alfa-2a - Hepatitis D, Chronic | Phase 3 | Completed | Hoffmann-La Roche | 31 | 2005-10-01 | 2016-08-26 |
Hepatitis D, Chronic (5) · Hepatitis B (2) · Hepatitis B, Chronic (1)
Digestive System Diseases (6) · Hepatitis (6) · Hepatitis, Viral, Human (6) · Infections (6) · Liver Diseases (6) · RNA Virus Infections (6) · Virus Diseases (6) · Chronic Disease (5) · Disease Attributes (5) · Hepatitis, Chronic (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Blood-Borne Infections (2) · Communicable Diseases (2)
peginterferon alfa-2a (3) · Ritonavir (2) · lonafarnib (2) · Tenofovir (1) · bulevirtide (1) · myrcludex-B (1) · peginterferon alfa-2b (1)
Hoffmann-La Roche (2) · Eiger BioPharmaceuticals (1) · Gilead Sciences (1) · Merck Sharp & Dohme LLC (1) · Soroka University Medical Center (1)
Turkey (Türkiye) (3) · Germany (2) · Israel (2) · Italy (2) · New Zealand (2) · Romania (2) · Russia (2) · Sweden (2) · United States (2) · Belgium (1) · Bulgaria (1) · Canada (1) · France (1) · Greece (1) · Moldova (1)
Ohad Etzion, MD (1)
PMID 30833068, PMID 37120031, PMID 37407002, PMID 38340811, PMID 39009085, PMID 39648559, PMID 41405233, PMID 41966308
2019 (1)